New hope for lymphoma patients: experimental drug enters human testing
NCT ID NCT05365659
Summary
This early-stage trial is testing a new experimental drug called IKS03 in adults with advanced B-cell non-Hodgkin lymphomas that have returned or stopped responding to standard treatments. The study aims to find the safest and most effective dose by first testing increasing amounts in small groups, then expanding to more patients. Researchers will monitor how the body handles the drug and look for early signs it can shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clinico Universitario de Salamanca
RECRUITINGSalamanca, Spain
Contact
Contact
-
Hospital Universitario Quironsalud Madrid
RECRUITINGMadrid, Spain
Contact
Contact
-
Institut Catala D'Oncologia
RECRUITINGBadalona, Spain
Contact
Contact
-
Istituto Europeo Clinico Humanitas
RECRUITINGMilan, Italy
Contact
Contact
-
Istituto Europeo di Oncologia
RECRUITINGMilan, Italy
Contact
Contact
-
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele
RECRUITINGMilan, Italy
Contact
Contact
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
Contact
Contact
-
La Fondazione e l'Istituto di Candiolo
RECRUITINGCandiolo, Italy
Contact
Contact
-
Linear Clinical Research
RECRUITINGPerth, Western Australia, Australia
Contact
Contact
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, Australia
Contact
Contact
-
Royal Hobart Hospital
RECRUITINGHobart, Tasmania, 7000, Australia
Contact
-
University of Maryland Baltimore
WITHDRAWNBaltimore, Maryland, 21201, United States
-
Westmead Hospital
RECRUITINGWestmead, New South Wales, 2145, Australia
Contact
Conditions
Explore the condition pages connected to this study.